Europe Swine Healthcare Market: By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Geography
Europe Swine Feed Market report gives a comprehensive outlook across the globe with special emphasis on key countries such as United Kingdom, Spain, Italy, Germany and the Rest of europe. The report gives historical, current, and future market sizes (US$ Mn) on the basis of feed type, feed additive type, feed essence and region. This report studies Europe Swine Feed Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged.
Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. Swine healthcare becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases.
Key Developments:
In September 2015, Boehringer Ingelheim Animal Health launched ingelvac PRRSFLEX EU for piglets and ReproCyc PRRS EU for sows for control of reproductive and respiratory syndrome.
Study Period
2024-2030Base Year
2023CAGR
X%Largest Market
N/AFastest Growing Market
N/A
Europe Swin e Healthcare Market Drivers are High demand for healthy pork meat coupled with increase in pork meat production, Rise in prevalence of various infectious and foodborne diseases and Increase in the R&D activities for the innovation of novel therapeutics and feed products. Restraints are Stringent regulatory guidelines for the swine vaccines and drug approvals and Adverse effects associated with the drugs.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
X% |
|
By Drugs |
|
|
By Feed Products |
|
|
By Disease Type |
|
|
By Route-Administration |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The Europe Swine Healthcare Market Report data: (Europe, Germany, France, Italy, United Kingdom (UK), Spain, Rest of EU)
The Europe Swine Healthcare Market key players are: Zoetis (Pfizer, Inc.) (U.S.) Merck & Co. Inc. (U.S) Virbac S.A. (France) Boehringer Ingelheim Vetmedica (Germany) Elanco (U.S.) Bayer Animal Health (Germany) Ceva Sante Animale (France) Wilbur-Ellis Feed, LLC (U.S.) Vetoquinol S.A. (France)
| 1. Executive Summary |
| 2. Europe Swine Healthcare Market Introduction |
| 2.1. Europe Swine Healthcare Market - Taxonomy |
| 2.2. Europe Swine Healthcare Market - Definitions |
| 2.2.1. Drugs |
| 2.2.2.Feed Products |
| 2.2.3.Disease Type |
| 2.2.4.Route-Administration |
| 2.2.5.Region |
| 3. Europe Swine Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Swine Healthcare Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Swine Healthcare Market By Drugs, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Vaccines |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Antibiotics |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Antifungals |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Parasiticides |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Anti-Viral Drugs |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Europe Swine Healthcare Market By Feed Products, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Nutritional Feed |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Medicated Feed |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Non-Medicated Feed |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Europe Swine Healthcare Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Viral Infections |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Bacterial Infections |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Parasitic Infection |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Fungal Infections |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Europe Swine Healthcare Market By Route-Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Oral |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Parenteral |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 9. Europe Swine Healthcare Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Europe |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Germany |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. France |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Italy |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. United Kingdom (UK) |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Spain |
| 9.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.6.3. Market Opportunity Analysis |
| 9.7. Rest of EU |
| 9.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.7.3. Market Opportunity Analysis |
| 10.Europe Europe Swine Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Drugs Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Vaccines |
| 10.1.2.Antibiotics |
| 10.1.3.Antifungals |
| 10.1.4.Parasiticides |
| 10.1.5.Anti-Viral Drugs |
| 10.1.6.Others |
| 10.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Nutritional Feed |
| 10.2.2.Medicated Feed |
| 10.2.3.Non-Medicated Feed |
| 10.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Viral Infections |
| 10.3.2.Bacterial Infections |
| 10.3.3.Parasitic Infection |
| 10.3.4.Fungal Infections |
| 10.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Oral |
| 10.4.2.Parenteral |
| 11. Germany Europe Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Vaccines |
| 11.1.2.Antibiotics |
| 11.1.3.Antifungals |
| 11.1.4.Parasiticides |
| 11.1.5.Anti-Viral Drugs |
| 11.1.6.Others |
| 11.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Nutritional Feed |
| 11.2.2.Medicated Feed |
| 11.2.3.Non-Medicated Feed |
| 11.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Viral Infections |
| 11.3.2.Bacterial Infections |
| 11.3.3.Parasitic Infection |
| 11.3.4.Fungal Infections |
| 11.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Oral |
| 11.4.2.Parenteral |
| 12. France Europe Swine Healthcare Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Vaccines |
| 12.1.2.Antibiotics |
| 12.1.3.Antifungals |
| 12.1.4.Parasiticides |
| 12.1.5.Anti-Viral Drugs |
| 12.1.6.Others |
| 12.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Nutritional Feed |
| 12.2.2.Medicated Feed |
| 12.2.3.Non-Medicated Feed |
| 12.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Viral Infections |
| 12.3.2.Bacterial Infections |
| 12.3.3.Parasitic Infection |
| 12.3.4.Fungal Infections |
| 12.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Oral |
| 12.4.2.Parenteral |
| 13. Italy Europe Swine Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Vaccines |
| 13.1.2.Antibiotics |
| 13.1.3.Antifungals |
| 13.1.4.Parasiticides |
| 13.1.5.Anti-Viral Drugs |
| 13.1.6.Others |
| 13.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Nutritional Feed |
| 13.2.2.Medicated Feed |
| 13.2.3.Non-Medicated Feed |
| 13.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Viral Infections |
| 13.3.2.Bacterial Infections |
| 13.3.3.Parasitic Infection |
| 13.3.4.Fungal Infections |
| 13.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Oral |
| 13.4.2.Parenteral |
| 14.United Kingdom (UK) Europe Swine Healthcare Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Drugs Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Vaccines |
| 14.1.2.Antibiotics |
| 14.1.3.Antifungals |
| 14.1.4.Parasiticides |
| 14.1.5.Anti-Viral Drugs |
| 14.1.6.Others |
| 14.2. Feed Products Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Nutritional Feed |
| 14.2.2.Medicated Feed |
| 14.2.3.Non-Medicated Feed |
| 14.3. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Viral Infections |
| 14.3.2.Bacterial Infections |
| 14.3.3.Parasitic Infection |
| 14.3.4.Fungal Infections |
| 14.4. Route-Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Oral |
| 14.4.2.Parenteral |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 15.2.2.Merck & Co. Inc. (U.S) |
| 15.2.3.Virbac S.A. (France) |
| 15.2.4.Boehringer Ingelheim Vetmedica (Germany) |
| 15.2.5.Elanco (U.S.) |
| 15.2.6.Bayer Animal Health (Germany) |
| 15.2.7.Ceva Sante Animale (France) |
| 15.2.8. Wilbur-Ellis Feed, LLC (U.S.) |
| 15.2.9.Vetoquinol S.A. (France) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Free Sample
